loader2
Partner With Us NRI

Vivanza Biosciences Ltd share Price Today

Company details

3.76
3.80
3.70
13.80
6M Return -41.45%
1Y Return -66.61%
Mkt Cap.(Cr) 15.20
Volume 72,676
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 72,676

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number

Vivanza Biosciences Ltd shares SWOT Analysis

Strengths (3)

  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Zero Promoter Pledge

Weakness (11)

  • Promoter holding decreased by more than -2% QoQ
  • Negative profit growth, promoters decreasing shareholding QoQ
  • Degrowth in Revenue and Profit

Opportunity (1)

  • Turnaround companies- loss to profit QoQ

Threats (5)

  • Promoter decreasing their shareholding
  • High PE (PE > 40)
  • Companies Increasing Debt as per Annual Report

Resistance and support

R1 3.8
R2 3.8
R3 3.9
Pivot

3.79

S1 3.8
S2 3.7
S3 3.7
EMA SMA
4.0
4.4
5.1
6.6
3.9
4.3
5.1
6.8
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
TANYA ESTATES PRIVATE LIMITED . Bulk Sell 2024-08-13 4.27 206927 BSE
ARDENT VENTURES LLP Bulk Sell 2024-04-09 9.37 2757649 BSE
ALKESHKUMAR DURLBHAJIBHAI SHELADIYA Bulk Purchase 2024-04-08 8.78 225000 BSE
Name Category Shares
PARTH HEMANT PARIKH PROMOTER 39.8%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Vivanza Biosciences Ltd Stocks COMPARISON

Financials( in Cr) Vivanza Biosciences Ltd Adani Enterprises Ltd Aegis Logistics Ltd Cello World Ltd Honasa Consumer Ltd
Price 3.80 3,130.30 738.85 880.55 456.95
% Change -2.56 1.18 -2.26 -0.70 -3.69
Mcap Cr 15.20 3,56,854.51 25,933.64 18,688.00 14,816.33
Revenue TTM Cr 27.84 96,420.98 7,045.92 2,000.26 1,919.90
Net Profit TTM Cr 0.55 3,294.63 672.20 356.18 110.53
PE TTM 47.50 83.63 44.44 57.83 117.68
1 Year Return -66.61 26.12 127.65 11.22 35.55
ROCE 10.23 8.94 16.09 35.64 16.12
ROE 12.60 9.14 18.10 47.95 -240.91
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 4.64 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 17,492.71 71,886.12
LAST 3M 78,204.11 61,813.64
LAST 6M 1,87,352.46 86,996.15
LAST 12M 3,32,953.72 1,53,700.57

Vivanza Biosciences Ltd Information

Stock PE (TTM)
47.5
Promoter Holding
40.05%
Book Value
1.1596
ROCE
10.23%
ROE
12.6%
Description
  • Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992. Head quartered in Gujarat, India, the Company came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. The Company is presently engaged in the business of Pharmaceutical Products and Pharma Products. However Competition in the industry is continuously increasing. New technology is being adopted and steps are taken to improve the manufacturing capacity of the Company. Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units. The company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa. It also proposed to diversify into the manufacture of small volume parenterals with an installed capacity of 294 lac pa. It came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers. Due to recessionary trends which lead to difficult business conditions in the year 1999-2000, the parenteral industry suffered a setback. As a result of this, the name of the Company was changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd in 2015. The Company acquired 100% Equity Shares of Vivanza Lifesciences Private Limited and by virtue of the holding in Vivanza Lifesciences Private Limited it became Wholly Owned Subsidiary w.e.f. 17/06/2016.

No Data Found

AGM Date (Month) : Jul
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 530057
NSE Code :
Book Closure Date (Month) : Jul
BSE Group : XT
ISIN : INE984E01035

FAQ’s on Vivanza Biosciences Ltd Shares

You can buy Vivanza Biosciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vivanza Biosciences Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 27, 2024 04:01 PM the closing price of Vivanza Biosciences Ltd was Rs.3.80.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 27, 2024 04:01 PM, the market cap of Vivanza Biosciences Ltd stood at Rs. 15.20 Cr.

The latest PE ratio of Vivanza Biosciences Ltd as of Sep 27, 2024 04:01 PM is 47.50

The latest PB ratio of Vivanza Biosciences Ltd as of Sep 27, 2024 04:01 PM is 0.31

The 52-week high of Vivanza Biosciences Ltd share price is Rs. 13.80 while the 52-week low is Rs. 3.70

According to analyst recommendations, Vivanza Biosciences Ltd Share has a "" rating for the long term.

Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number